For one breast cancer tissue core, the HER2 gene-protein assay revealed the heterogeneity of HER2 protein status with HER2 IHC 3+, 2+, and 1+ cell populations visible within the same area (Figure 5A). Here, ERBB2 is linked to breast carcinoma.